‘Hunker Down, Expect The Worst And Hope For The Best’: Investment Analyst Advises Medtech Businesses To Cut Costs
Executive Summary
Maxim Jacobs, managing partner at Edison Investment Research, urges medtech companies to be financially prudent as the COVID-19 pandemic worsens. Cancellations of routine surgeries are creating a huge strain on device businesses which could continue for months.